Willow

Overview

Willow positions its oral GLP-1 program as a structured weight management journey rather than a medication subscription, emphasizing the progress tracking and follow-up support infrastructure that converts GLP-1 efficacy into sustainable long-term outcomes. For patients who have learned from experience that medication alone does not produce lasting results, Willow’s structured support model provides the behavioral scaffolding that makes the difference. Telehealth-first weight management program with wellness tracking and follow-up support. Treatment is available only when a licensed clinician determines it is medically appropriate. Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.